Compositions and methods for treating psoriasis by...

Details Compositions and methods for treating psoriasis by... Compositions and methods for treating psoriasis by...

2011-05-24

2011-05-24

Flood, Michele (Department: 1655)

Drug, bio-affecting and body treating compositions

Extract or material containing or obtained from a...

C514S863000

Reexamination Certificate

active

07947283

ABSTRACT:
A method for treating psoriasis by providing a pharmaceutical composition containing at leastGanoderma lucidumextract and administering a therapeutically effective amount of the composition to a patient in need thereof. Also disclosed is a method for treating psoriasis by first purifyingGanoderma lucidumextract into at least one fraction, then providing a pharmaceutical composition comprising at least one of theGanoderma lucidumfractions, and administering a therapeutically effective amount of the composition to a patient in need thereof. A method for alleviating symptoms of psoriasis is disclosed. The symptoms of psoriasis are alleviated by providing a pharmaceutical composition containing at leastGanoderma lucidumextract and administering an amount of the composition effective to increase at least one of an IL-10 and IL-1Ra expression, whereby the symptoms of psoriasis are ameliorated.

REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 5334704 (1994-08-01), Tsunoo et al.
patent: 5863769 (1999-01-01), Young
patent: 5997875 (1999-12-01), Zhou et al.
patent: 6395310 (2002-05-01), Iwasaki
patent: 6464982 (2002-10-01), Lam
patent: 6471860 (2002-10-01), Miltenyi et al.
patent: 6613754 (2003-09-01), Wu
patent: 7135183 (2006-11-01), Wang et al.
patent: 7323176 (2008-01-01), Wang et al.
patent: 2003/0095981 (2003-05-01), Wong et al.
patent: 2003/0068329 (2003-10-01), Kosuna et al.
patent: 2005/0180988 (2005-08-01), Chung et al.
patent: 2007/0104729 (2007-05-01), Wang et al.
patent: 2007/0105814 (2007-05-01), Hua et al.
patent: 2007/0231339 (2007-10-01), Yu et al.
patent: 2008/0214442 (2008-09-01), Yu et al.
patent: 2008/0247989 (2008-10-01), Shih et al.
patent: WO/2006/044616 (2006-04-01), None
patent: WO/2007/047021 (2007-04-01), None
patent: WO/2008/036421 (2008-03-01), None
Blomberg K. et al.,Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity, J. Immunol. Methods, 1993, vol. 160, pp. 27-34.
Bowden, R. et al.,Alteration of Cytokine Levels in Murine Retrovirus Infection: Modulation by Combination Therapy, International Journal of Immunopharmacology 1999, vol. 21, pp. 815-827.
Braciale T. et al.,Antigen presentation: structural themes and functional variations, Immunology Today, 1991, vol. 12, No. 4, pp. 124-129.
Bronte V. et al.,IL-2 Enhances the Function of Recombinant Poxvirus-Based Vaccines in the Treatment of Established Pulmonary Metastases, J. Immunol., 1995, vol. 154, pp. 5282-5292.
Chen H. et al.,Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum(Reishi)polysaccharides, Bioorg. Med. Chem., 2004, vol. 12, pp. 5595-5601.
Chen-Bettecken U. et al.,IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures, Proc. Natl. Acad. Sci., USA, 1985, vol. 82, pp. 7384-7388.
Chien C.,Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+NK-cell cytotoxicity in cord blood, Bioorg. Med. Chem., 2004, vol. 12, pp. 5603-5609.
Feltkamp M. et al.,Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type I6-induced tumors, Eur. J. Immunol., 1995, vol. 25, pp. 2638-2642.
Franz, G.,Polysaccharides in Pharmacy: Current Applications and Future Concepts, Planta Medica, 1989, vol. 55, pp. 493-497.
Furusawa, E. et al.,Antitumor Activity of Ganoderma lucidum, an Edible Mushroom, on Intraperitoneally Implanted Lewis Lung Carcinoma in Synergenic Mice, Phytotherapy Research, vol. 6, 1992, pp. 300-304.
Grohmann U. et al,CD8+cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tumor helper peptides in priming for skin test reactivity to a P815AB-related peptide, Eur. J. Immunol., 1995, vol. 25, pp. 2797-2802.
Halhoul M. et al.,Differential Determination of Glucose and Fructose, and Glucose- and Fructose-Yielding Substances with Anthrone, Anal. Biochem., 1972, vol. 50, pp. 337-343.
Hellman M. et al.,Separation of Isomeric Polyphenyls by Adsorption Chromatography, 1990, Analytical Chemistry, pp. 1206-1210.
Henderson R. et al.,Human Tumor Antigens are Ready to Fly, Advances in Immunology, 1996, vol. 62, pp. 217-256.
Hsu H. et al.,Extract of Reishi Polysaccharides Induces Cytokine Expression via TLR4-Modulated Protein Kinase Signaling Pathways, J. Immunol., 2004, vol. 173, pp. 5989-5999.
Jermyn M.,Increasing the Sensitivity of the Anthrone Method for Carbohydrate, Anal. Biochem., 1975, vol. 68, pp. 332-335.
Kim B. et al.,Antineoplastic Components of Korean Basidomycetes, Korean Journal of Mycology, 1980, vol. 8, No. 2, pp. 107-114.
Kovacsovics-Bankowski M. et al.,A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules, Science, 1995, vol. 267, pp. 243-246.
Lin K. et al.,Reishi Polysaccharides Induce Immunoglobulin Production through the TLR4/TLR2-mediated Induction of Transcription Factor Blimp-1, J. Biol. Chem., 2006, vol. 281, No. 34, pp. 24111-24123.
Lo C. et al.,Simple fractionation of phospholipase A2analogues from snake venom by high-performance liquid chromatography, J. Chromatogr. 1990, vol. 530, pp. 129-136.
Miyazaki, T. et al.,Structural Examination of an Alkali-Extracted, Water-Soluble Heteroglycan of the Fungus Ganoderma lucidum, Carbohydrate Research, 1982, vol. 109, pp. 290-294.
Mizuno et al.,Fractionation, Chemical Modification and Antitumor Activity of Water-insoluble Polysaccharides of the Fruiting Body of Ganoderma lucidum, Journal of the Agricultural Chemical Society of Japan (Nippon Nôgeikagaku Kaishi), 1985, vol. 59, No. 11, pp. 1143-1151. [English language abstract enclosed].
Mosmann, T.,Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays, Journal of Immunological Methods, 1983, vol. 65, pp. 55-63.
Müller A. et al.,Receptor Binding and Internalization of a Water-Soluble(1→3)-β-D-Glucan Biologic Response Modifier in Two Monocyte/Macrophage Cell Lines, J. Immunol., 1996, vol. 156, pp. 3418-3425.
Murphy, E. et al.,Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni Infected Mice, Journal of Immunological Methods, 1993, vol. 162, pp. 211-223.
Norkin L. et al.,Association of Caveolin with Chlamydia trachomatis Inclusions at Early and Late Stages of Infection, Exp. Cell. Res., 2001, vol. 266, pp. 229-238.
Puccetti P. et al.,Use of a skin test assay to determine tumor-specific CD8+T cell reactivity, Eur. J. Immuno., 1994, vol. 24, pp. 1446-1452.
Robbins P. et al.,A Mutated β-Catenin Gene Encodes a Melanoma-specific Antigen Recognized by Tumor Infiltrating Lymphocytes, J. Exp. Med., 1996, vol. 183, pp. 1185-1192.
Sanchez, J. et al.,The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity, Proteomics, 2001, vol. 1, pp. 136-163.
Shaffer A.,XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell Differentiation, Immunity, 2004, vol. 21, pp. 81-93.
Shao B. et al.,Immune receptors for polysaccharides from Ganoderma lucidum, Biochem. Biophys. Res. Commun., 2004, vol. 323, pp. 133-141.
Shapiro-Shelef M. et al.,Blimp-1 Is Required for the Formation of Immunoglobulin Secreting Plasma Cells and Pre-Plasma Memory B Cells, Immunity, 2003, vol. 19, pp. 607-620.
Shiao M. et al.,Natural Products and Biological Activities of the Chinese Medicinal Fungus Ganoderma lucidum, American Chemical Society, 1994, pp. 342-354.
Sieckmann D. et al.,Activation of Mouse Lymphocytes by Anti-Immunoglobulin, J. Exp. Med., 1978, vol. 147, pp. 814-829.
Smith J. et al.,Current Protocols in Molecular Biology, John Wiley & Sons, Inc., 2005, Sec. 11.1-11.3.
Somani B. et al.,A Modified Anthrone-Sulfuric Acid Method for the Determination of Fructose in the Presence of Certain Proteins, Anal. Biochem., 1987, vol. 167, p. 327-330.
Sone Y. et al.Structures and Antitumor Activities of the Polysacchari

Affiliated with

Also associated with

Rating

Compositions and methods for treating psoriasis by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treating psoriasis by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating psoriasis by... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2626744